Studies on mouse models of breast cancer have documented that IL-10 secreted by TAMs prevents CD8+ T cell cytotoxic activity by inhibiting IL-12 expression on dendritic cells required for anti-tumoral differentiation of T cells into T helper-1 (Th1) cells (30). This evidence concerns the gene CD8A and breast carcinoma.